PARIS, Jan. 6, 2016 /PRNewswire/ -- European Capital announced today that an affiliate, European Capital Debt Management Limited, arranged and an affiliated fund underwrote the €40 million unitranche financing supporting the acquisition of Euromed (or the "Company") by The Riverside Company.
Euromed is a leading manufacturer of niche herbal extracts and active ingredients, mostly used in over-the-counter pharmaceutical applications, food supplements and cosmetics. Founded in 1971, Euromed has developed close and loyal relationships with its 350 customers who predominantly operate in the highly protected and demanding pharmaceutical space. Headquartered in Spain, Euromed sells 95% of its products abroad in 35 different countries located mainly in Europe and the Americas. Despite the global financial crisis, the Company achieved healthy profitable growth over the recent years due to successfully growing its reach in the food supplements and U.S. markets.
"We are pleased to partner with The Riverside Company and to support its acquisition of Euromed," stated Tristan Parisot, Managing Director of European Capital in Paris. "Spain has become a very attractive market for private debt lenders. We have looked at many opportunities in Spain over the last twelve months and this first unitranche financing confirms our ability to provide tailor-made solutions to leading mid-market private equity sponsors looking to invest in Spain."
"With a proven track record of high-quality herbal extracts, a complete control over the value chain and the support of The Riverside Company, we are firmly convinced that Euromed is well-positioned to further expand internationally in the U.S. and Asia and pursue its successful penetration of the high-end food supplements market," added Kevin Abrial, Director at European Capital.
"The Riverside Company is very pleased to partner with European Capital," said Karsten Langer, Partner at The Riverside Company. "We appreciate European Capital's professionalism, flexibility and capacity to value the Company's strategic strengths and opportunities, which position it as a partner of choice for Euromed."
ABOUT EUROPEAN CAPITAL
European Capital, both directly and through its asset management business, invests in pan-European equity, mezzanine and senior debt investments. European Capital is a wholly-owned affiliate of American Capital, Ltd. (Nasdaq: ACAS). European Capital manages €0.9 billion of assets.
European Capital invests in and sponsors management and employee buyouts, invests in private equity buyouts and provides capital directly to private and public companies headquartered predominantly in Europe. European Capital will consider senior, mezzanine, subordinated and unitranche debt investment opportunities from 10 million to 100 million in either euros or sterling and up to 300 million One Stop Buyouts®. For further information, please refer to www.EuropeanCapital.com.
ABOUT AMERICAN CAPITAL
American Capital, Ltd. (Nasdaq: ACAS) is a publicly traded private equity firm and global asset manager. American Capital, both directly and through its asset management business, originates, underwrites and manages investments in middle market private equity, leveraged finance, real estate and structured products. American Capital manages $23 billion of assets, including assets on its balance sheet and fee earning assets under management by affiliated managers, with $80 billion of total assets under management (including levered assets). Through a wholly-owned affiliate, American Capital manages publicly traded American Capital Agency Corp. (Nasdaq: AGNC), American Capital Mortgage Investment Corp. (Nasdaq: MTGE) and American Capital Senior Floating, Ltd. (Nasdaq: ACSF) with approximately $10 billion of total net book value. From its eight offices in the U.S., Europe and Asia, American Capital and European Capital will consider investment opportunities from $10 million to $600 million. For further information, please refer to www.AmericanCapital.com.
Contact: European Capital, + 33 1 40 68 06 66
Tristan Parisot, Managing Director and Head of Paris Office
Kevin Abrial, Director
SOURCE European Capital